- Surviving in the era of "Big Data"
-
Kwon SW
- KMID: 2270699
- Blood Res.
- 2013 Sep;48(3):167-168.
- doi: 10.5045/br.2013.48.3.167
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Multiple myeloma with spindle-like cell morphology
-
Park J
- KMID: 2270700
- Blood Res.
- 2013 Sep;48(3):169-169.
- doi: 10.5045/br.2013.48.3.169
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Fighting back against chronic myelomonocytic leukemia
-
Jo DY
- KMID: 2270698
- Blood Res.
- 2013 Sep;48(3):165-166.
- doi: 10.5045/br.2013.48.3.165
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Waldenstrom's macroglobulinemia presenting with lytic bone lesions: a rare presentation
-
Pujani M, Kushwaha S, Sethi N, Beniwal A, Shukla S
- KMID: 2270713
- Blood Res.
- 2013 Sep;48(3):230-233.
- doi: 10.5045/br.2013.48.3.230
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Solitary pulmonary plasmacytoma
-
Ryu H, Lee C, Jo DY
- KMID: 2270701
- Blood Res.
- 2013 Sep;48(3):170-170.
- doi: 10.5045/br.2013.48.3.170
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Relationship between bortezomib-containing regimens and the incidence of tuberculosis in patients with myeloma
-
Kim K, Kim SJ, Maeng CH
- KMID: 2270714
- Blood Res.
- 2013 Sep;48(3):233-234.
- doi: 10.5045/br.2013.48.3.233
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- BK virus encephalitis without concurrent hemorrhagic cystitis in an allogeneic hematopoietic stem cell transplant recipient
-
Lee SY, Lee SR, Kim DS, Choi CW, Kim BS, Park Y
- KMID: 2270711
- Blood Res.
- 2013 Sep;48(3):226-228.
- doi: 10.5045/br.2013.48.3.226
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Concomitant transformation of monoclonal gammopathy of undetermined significance to multiple myeloma and of essential thrombocythemia to acute biphenotypic leukemia 37 years after initial diagnosis
-
Niscola P, Catalano G, Fratoni S, Scaramucci L, de Fabritiis P, Caravita T
- KMID: 2270712
- Blood Res.
- 2013 Sep;48(3):228-230.
- doi: 10.5045/br.2013.48.3.228
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A case of myelodysplastic syndrome with marked eosinophilia showing favorable prognosis
-
Kim MJ, Bae SH, Lee AJ, Kim SG
- KMID: 2270710
- Blood Res.
- 2013 Sep;48(3):222-225.
- doi: 10.5045/br.2013.48.3.222
Myelodysplastic syndrome (MDS) with eosinophilia is a rare condition and has yet to be classified under the 2008 World Health Organization classification. However, reports have described the prognostic significance of... -
- CITED
-
- Close
- SHARE
-
- Close
- Review of the clinical research conducted by the Consortium for Improving Survival of Lymphoma of the Korean Society of Hematology Lymphoma Working Party
-
Suh C, Kim WS, Kim JS, Park BB
- KMID: 2270702
- Blood Res.
- 2013 Sep;48(3):171-177.
- doi: 10.5045/br.2013.48.3.171
The Consortium for Improving Survival of Lymphoma (CISL) in Korean Society of Hematology Lymphoma Working Party had first meeting in February, 2006 with 10 institutions and 12 members. Now CISL... -
- CITED
-
- Close
- SHARE
-
- Close
- Mean cell volumes of neutrophils and monocytes are promising markers of sepsis in elderly patients
-
Lee AJ, Kim SG
- KMID: 2270705
- Blood Res.
- 2013 Sep;48(3):193-197.
- doi: 10.5045/br.2013.48.3.193
BACKGROUND: Sepsis in elderly patients is a major cause of morbidity and mortality in the clinical setting. The aim of this study was to assess the diagnostic significance of volume... -
- CITED
-
- Close
- SHARE
-
- Close
- Sequence variation data of F8 and F9 genes in functionally validated control individuals: implications on the molecular diagnosis of hemophilia
-
Seo JY, Jang MA, Kim HJ, Lee KO, Kim SH, Kim HJ
- KMID: 2270707
- Blood Res.
- 2013 Sep;48(3):206-210.
- doi: 10.5045/br.2013.48.3.206
BACKGROUND: The F8 and F9 genes encode for coagulation factor VIII (FVIII) and FIX, respectively, and mutations in these genes are the genetic basis of hemophilia A/B. To determine whether... -
- CITED
-
- Close
- SHARE
-
- Close
- Unexpected red cell antibody detection by conditional combination of LISS/Coombs and NaCl/Enzyme gel tests at a tertiary care hospital in Korea: A 5-year study
-
Shin JW
- KMID: 2270709
- Blood Res.
- 2013 Sep;48(3):217-221.
- doi: 10.5045/br.2013.48.3.217
BACKGROUND: A combination of the LISS/Coombs and enzyme methods is recommended for identifying unexpected antibodies. However, many laboratories in which tests are to be performed within the limits of medical... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of prognostic factors in patients with therapy-related acute myeloid leukemia
-
Park SH, Chi HS, Cho YU, Jang S, Park CJ
- KMID: 2270704
- Blood Res.
- 2013 Sep;48(3):185-192.
- doi: 10.5045/br.2013.48.3.185
BACKGROUND: Therapy-related AML (t-AML) occurs as a late complication of chemotherapy administered to treat a prior disorder. Prognostic factors affecting the clinical outcome in t-AML have not yet been clearly... -
- CITED
-
- Close
- SHARE
-
- Close
- Allogeneic hematopoietic cell transplantation in adult patients with myelodysplastic/myeloproliferative neoplasms
-
Lim SN, Lee JH, Lee JH, Kim DY, Kim SD, Kang YA, Lee YS, Lee KH
- KMID: 2270703
- Blood Res.
- 2013 Sep;48(3):178-184.
- doi: 10.5045/br.2013.48.3.178
BACKGROUND: In adults, the 2 main types of myelodysplastic/myeloproliferative neoplasms (MDS/MPN) are chronic myelomonocytic leukemia (CMML) and atypical chronic myeloid leukemia (aCML). Both are associated with a poor prognosis. Allogeneic... -
- CITED
-
- Close
- SHARE
-
- Close
- Hereditary hemolytic anemia in Korea from 2007 to 2011: A study by the Korean Hereditary Hemolytic Anemia Working Party of the Korean Society of Hematology
-
Park ES, Jung HL, Kim HJ, Park SS, Bae SH, Shin HY, Song SH, Koh KN, Lyu CJ, Lim YT, Han DK, Hah JO
- KMID: 2270708
- Blood Res.
- 2013 Sep;48(3):211-216.
- doi: 10.5045/br.2013.48.3.211
BACKGROUND: The number of patients diagnosed with hereditary hemolytic anemia (HHA) has increased since the advent of novel diagnostic techniques that accurately identify this disorder. Here, we report data from... -
- CITED
-
- Close
- SHARE
-
- Close
- The impact of novel therapeutic agents before and after frontline autologous stem cell transplantation in patients with multiple myeloma
-
Min CK, Lee SE, Yahng SA, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Cho SG, Kim DW, Lee JW, Min WS, Park CW
- KMID: 2270706
- Blood Res.
- 2013 Sep;48(3):198-205.
- doi: 10.5045/br.2013.48.3.198
BACKGROUND: Novel agents (NAs) such as thalidomide and bortezomib have been administered in combination with autologous stem-cell transplantation (ASCT) to effectively treat multiple myeloma (MM). However, whether NAs perform better... -
- CITED
-
- Close
- SHARE
-
- Close
